Jeanne E. Poole

Active 1990–2025

67
Papers
20,458
Citations
55
h-index
67
i10-index

Citations

Citations per year for Jeanne E. Poole1964: 1 citations1992: 3 citations1993: 9 citations1994: 12 citations1995: 20 citations1996: 16 citations1997: 5 citations1998: 13 citations1999: 12 citations2000: 9 citations2001: 17 citations2002: 7 citations2003: 8 citations2004: 1 citations2005: 46 citations2006: 81 citations2007: 59 citations2008: 83 citations2009: 100 citations2010: 101 citations2011: 77 citations2012: 101 citations2013: 74 citations2014: 87 citations2015: 101 citations2016: 54 citations2017: 88 citations2018: 45 citations2019: 300 citations2020: 372 citations2021: 424 citations2022: 442 citations2023: 383 citations2024: 688 citations2025: 319 citations2026: 8 citations1965–1991: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,665 citing papers, 23.3% of this breakdownUnited Kingdom: 553 citing papers, 7.8% of this breakdownGermany: 438 citing papers, 6.1% of this breakdownItaly: 416 citing papers, 5.8% of this breakdownCanada: 377 citing papers, 5.3% of this breakdownNetherlands: 358 citing papers, 5% of this breakdownChina: 257 citing papers, 3.6% of this breakdownFrance: 249 citing papers, 3.5% of this breakdownAustralia: 237 citing papers, 3.3% of this breakdownSpain: 194 citing papers, 2.7% of this breakdownDenmark: 187 citing papers, 2.6% of this breakdownJapan: 169 citing papers, 2.4% of this breakdown
0%23.3%Other 28.6%

Fields

  • Medicine93.5%
  • Engineering1.5%
  • Biochemistry, Genetics and Molecular Biology1.5%
  • Health Professions0.6%
  • Neuroscience0.5%
  • Economics, Econometrics and Finance0.5%
  • Other1.9%

Topics

  • Cardiac pacing and defibrillation studies14.3%
  • Cardiac Arrhythmias and Treatments9.9%
  • Cardiac electrophysiology and arrhythmias8.8%
  • Atrial Fibrillation Management and Outcomes8.4%
  • Heart Failure Treatment and Management4.2%
  • Cardiovascular Function and Risk Factors4.1%
  • Other50.3%

Coauthors

All papers

Open in search
  1. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030

    Authors: , , , , , , , , , , , , , , , , - The Lancet 2021 cited by 1,414

  2. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2019 cited by 1,465

  3. Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2005 cited by 6,526

  4. Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure

    Authors: , , , , , , , , , , - Circulation 2021 cited by 471

  5. Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation

    Authors: , , , , , , , , , , , , - JAMA 2019 cited by 605

  6. Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert W. Rho, Andrea M. Russo, Eric C. Stecker, Wendy S. Tzou, Laura Vitali Serdoz, Mauri Wilson - Journal of the American College of Cardiology 2020 cited by 261

  7. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections—endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Annelies S. Zinkernagel, Emanuele Durante‐Mangoni - EP Europace 2019 cited by 406

  8. Antibacterial Envelope to Prevent Cardiac Implantable Device Infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 cited by 387

  9. Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results From the CABANA Trial

    Authors: , , , , , , , , , , - Circulation 2021 cited by 110

  10. Prognostic Importance of Defibrillator Shocks in Patients with Heart Failure

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2008 cited by 1,456

  11. 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John Whittle, Kim A. Williams - Circulation 2024 cited by 274

  12. Increasing Participation of Women in Cardiovascular Trials

    Authors: , , , , , , , , , - Journal of the American College of Cardiology 2021 cited by 142

  13. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections—endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

    Authors: , , , , , , , , , , , , , , , - European Heart Journal 2020 cited by 213

  14. Prognostic Value of Late Gadolinium Enhancement for the Prediction of Cardiovascular Outcomes in Dilated Cardiomyopathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Circulation Cardiovascular Imaging 2020 cited by 109

  15. 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John Whittle, Kim A. Williams - Journal of the American College of Cardiology 2024 cited by 145

  16. Arrhythmias in Female Patients: Incidence, Presentation and Management

    Authors: , , , , , , , , , , , , , , , , , - Circulation Research 2022 cited by 51

  17. Complication Rates Associated With Pacemaker or Implantable Cardioverter-Defibrillator Generator Replacements and Upgrade Procedures

    Authors: , , , , , , , , , , , , , , , , - Circulation 2010 cited by 779

  18. Impact of Cardiac Implantable Electronic Device Infection

    Authors: , , , , , , , , , , , , , , , , - Circulation Arrhythmia and Electrophysiology 2020 cited by 83

  19. Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANA

    Authors: , , , , , , , , , , - EP Europace 2022 cited by 36

  20. Thyroid Function in Heart Failure and Impact on Mortality

    Authors: , , , , , , , - JACC Heart Failure 2013 cited by 138

  21. Cardiac implantable electronic device infections: Who is at greatest risk?

    Authors: , , , , - Heart Rhythm 2017 cited by 102

  22. Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical Trial

    Authors: , , , , , , , , , , , , , , - Circulation 2022 cited by 70

  23. The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the Perioperative Management of Patients with Implantable Defibrillators, Pacemakers and Arrhythmia Monitors: Facilities and Patient Management

    Authors: , , , , , , , , , , , , , - Heart Rhythm 2011 cited by 331

  24. A novel method to predict the proportional risk of sudden cardiac death in heart failure: Derivation of the Seattle Proportional Risk Model

    Authors: , , , , , , , , , , - Heart Rhythm 2015 cited by 104